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Abstract
Extracellular matrix production and accumulation stabilize the heart under normal conditions
as well as form a protective scar after myocardial infarction injury, although excessive extra-
cellular matrix accumulation with long-standing heart disease is pathological. In the current
study we investigate the role of the matricellular protein, transforming growth factor beta-
induced (TGFBI), which is induced in various forms of heart disease. Additionally, we sought
to understand whether TGFBI is functionally redundant to its closely related family member
periostin, which is also induced in the diseased heart. Surgical models of myocardial infarc-
tion and cardiac pressure overload were used in mice with genetic loss of Postn and/or Tgfbi
to examine the roles of these genes during the fibrotic response. Additionally, cardiac-spe-
cific TGFBI transgenic mice were generated and analyzed. We observed that deletion of
Tgfbi did not alter cardiac disease after myocardial infarction in contrast to greater ventricu-
lar wall rupture in Postn gene-deleted mice. Moreover, Tgfbi and Postn double gene-deleted
mice showed a similar post-myocardial infarction disease phenotype as Postn-deleted
mice. Over-expression of TGFBI in the hearts of mice had a similar effect as previously
shown in mice with periostin over-expression. Thus, TGFBI and periostin act similarly in the
heart in affecting fibrosis and disease responsiveness, although TGFBI is not seemingly
necessary in the heart after myocardial infarction injury and is fully compensated by the
more prominently expressed effector periostin.
Introduction
Cardiovascular disease remains the leading cause of death in the United States affecting more
than 85 million people at an estimated annual cost of more than $300 billion [1]. A wide array
of cardiovascular disease etiologies often culminate in heart failure, which is characterized by
progressive cardiomyocyte cell death and the accumulation of excessive extracellular matrix
(ECM) with adverse ventricular remodeling [2, 3]. However, ECM deposition after acute myo-
cardial infarction (MI) injury is critical in facilitating scar formation to protect the ventricular
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wall from rupture. In longstanding chronic heart disease states, excess deposition of ECM
leads to decreased ventricular wall compliance with reduced function [2]. Current therapeutics
that specifically target excessive fibrosis and ECM production in chronic heart failure are lack-
ing but desperately needed. Hence, it remains critical to understand the underlying mecha-
nisms and associated genes whereby ECM accumulates in the heart during chronic disease
states.
Transforming growth factor beta-induced (TGFBI) is a 68 kDa matricellular protein and a
member of the fasciclin domain containing protein family that also includes periostin [4]. As a
secreted protein that resides within the ECM, TGFBI affects cell migration and proliferation in
models of cancer [5–9]. TGFBI shares substantial amino acid sequence similarity with perios-
tin and a highly conserved protein domain structure [10]. Both TGFBI and periostin are evolu-
tionarily conserved with a single paralog being present in Drosophila, suggesting that such
proteins play an important role in biology [11]. Several studies have demonstrated the impor-
tance of periostin in facilitating collagen maturation and matrix production with proper scar
formation in the hearts of mice after MI injury [12, 13]. In addition to facilitating collagen
organization and cross-linking, periostin can interact with fibronectin and tenascin-C in gen-
erating additional ECM structural capacity [14]. Characterization of TGFBI in disease has pri-
marily focused on corneal dystrophy where human mutations in the gene encoding this
protein cause aberrant folding leading to TGFBI aggregation in the cornea resulting in blind-
ness [15–17]. Tgfbinull mice showed morphologically altered lungs from prior aberrant devel-
opmental maturation as well as augmented myofibroblast numbers throughout this organ
[18].
Given the significant similarity between periostin and TGFBI, we hypothesized that these
proteins may have overlapping functions during cardiac ventricular remodeling. Previous
studies have shown that periostin is robustly increased after injury in the heart and is required
for adequate scar formation after MI [12, 13, 19, 20]. TGFBI mRNA is also induced in the
injured heart [21], although, there have been no functional studies specifically addressing the
role of this protein in the heart.
Materials and methods
Mice
Mice with genetic deletion of Postn and Tgfbiwere previously described and were maintained
as a mixed C57Bl/6-Sv129 background [12, 18]. To generate transgenic mice over-expressing
TGFBI, the human TGFBI cDNA was cloned downstream of a modified tetracycline inducible
α-myosin heavy chain (MHC) promoter construct, which was injected into newly fertilized
mouse oocytes in the FVB/N background [22]. This allowed for the tetracycline/doxycycline
inducible expression of TGFBI specifically in the heart when crossed with transgenic mice
expressing the tet-transactivator (tTA) protein, also driven by the α-MHC promoter [22].
Primers used for genotyping were 5’-AAGTCTCTCCAAGGTGACAAGC-3’ and 5’-AGAAG
GACACCTAGTCAGAC-3’ for the TGFBI transgene and 5’-AGCGCATTAGAGCTGCTTAAT
GAGGTC-3’ and 5’-GTCGTAATAATGGCGGCATACTATC-3’ for the tet-transactivator
transgene.
Animal husbandry and ethics statement
Mice were housed in standard barrier rack cages supplied with Purina Rodent Chow 5001
with automatic watering dispensers. Cages were observed daily and were changed weekly by
certified veterinary technicians at Cincinnati Children’s Hospital Medical Center. Mice were
also closely assessed for their well-being monitored by adequate physical activity and food
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intake on a daily basis. Housing conditions and husbandry conformed to AAALAC standards
and the institution’s ongoing certification by this organization, as well as by the standard
guidelines from the Office of Laboratory Animal Welfare (http://grants.nih.gov/grants/olaw/
animal_use.htm). All animal experimentation, including this specific study, was approved by
the Office of Research Compliance and Regulatory Affairs and by the Cincinnati Children’s
Hospital Institutional Animal Care and Use Committee (Protocol Number: IACUC 2016–
0069, expires 11–2019). No human subjects were used.
Echocardiography and surgical models of MI and TAC
Echocardiographic measurements were performed under 2.0% isoflurane anesthesia using a
Hewlett Packard SONOS 5500 instrument [12]. Transverse aortic constriction (TAC) surgery
as a model of cardiac pressure overload was performed in 8–12 week-old mice and cardiac
functional characteristics were monitored with M-mode echocardiography every 2 weeks until
the experiment was completed 12 weeks later [12, 23]. The TAC procedure was performed
under 2% isoflurane-induced anesthesia. TAC operated mice were monitored daily by veteri-
nary technicians for signs of distress and heart failure including lethargy, difficulty breathing
and decreased physical activity. When any of these metrics differed substantially between sham
and TAC operated animals, treatments including analgesic, IV fluids and soft diet were admin-
istered. Mice were under the care of a veterinarian and were monitored for improvement. If
there was no improvement in symptoms after 24 hours, the mice were sacrificed. For MI sur-
gery, the left coronary artery of 6–8 week-old mice was permanently occluded and M-mode
echocardiography was used to monitor cardiac functional characteristic at 1, 3, 5 and 8 weeks
post-surgery [12, 23]. For the MI procedure, 2% isoflurane-induced anesthesia was given to
the mice until sedated as assessed by toe pinch. At the end of all surgical procedures, mice were
given the pain medicine buprenex at a final concentration of 0.03 mg/ml by veterinary techni-
cians. Mice were then transferred to a 30˚C chamber and closely monitored to allow overnight
recovery. The next day, mice were transferred back to standard housing and again monitored
daily by veterinary technicians. Equal ratios of male and female mice were used in all experi-
ments and procedures. At the end of the 8 week experiment, mice were anesthetized with 2.0%
isoflurane until fully sedated before sacrifice. The mice were then cervically dislocated and the
hearts were injected with 1 M KCl to arrest them in diastole. Hearts were either fixed in 10%
buffered formalin for histological analysis or flash frozen for protein analysis.
Survival study
Mice were assessed daily by AAALAC certified veterinary technicians at Cincinnati Children’s
Hospital Medical Center for health and well-being including physical activity and food and
water intake. Complications associated with surgical intervention were also monitored includ-
ing lethargy and signs of heart failure. Mice were under veterinarian care to manage any signs
of distress and provided with analgesics as needed or IV fluids with a special soft diet to
accommodate recovery from surgical procedures. CCHMC’s IACUC committee has reviewed
and approved the experiments for this study including anticipated mortality rates due to both
surgical complications and study related events. Survival was monitored for 1 week after MI
surgery in which mice died abruptly from ventricular wall rupture. To produce statistically
meaningful numbers of mice that survived the 8 week experiment, a total of 147 mice were
used for MI surgery (WT = 56 (26), Tgfbi-/- = 45 (24), Postn-/- = 23 (17) and DKO = 23 (19))
with the number of mice that died included in parentheses. All mice that died were necropsied
to assess cardiac ventricular wall rupture as a cause of death. Mouse experimentation to assess
cardiac rupture was required due to the lack of in vitro models of this process.
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Model of acute lung injury
Lung injury in mice was induced by intranasal administration of 0.05 U of bleomycin (Teva
Pharmaceuticals, NDC# 00703-3154-01), a well-known inducer of idiopathic pulmonary fibro-
sis [24–26], once a week for three weeks under 2.0% isoflurane anesthesia. Lungs were har-
vested one week after the final treatment and flash frozen before processing for protein
analysis. No pain relief was deemed necessary for this procedure given the need to induce a
fibrotic response in the lungs and because the procedure does not elicit a noticeable pain
response in the mice.
Cell isolation and Western blotting
Adult cardiomyocytes were isolated from 8-week old wildtype (WT) mice as previously
described [27, 28]. Briefly, beating hearts were removed from anesthetized mice (as described
above) and cannulated for perfusion with modified Tyrode solution (120 mL NaCl, 5.4 mM
KCl, 1.2 mM NaH2PO4, 5.6 mM glucose, 20 mM NaHCO3, 1.6 mM MgCl2, 10 mM 2,3-buta-
nedione monoxime (BDM) and 5 mM taurine; buffer A). Hearts were then perfused with
buffer A containing liberase blendzyme (Roche, cat# 05401151001) at 37˚C. After perfusion,
atria were excised and hearts were dissociated into individual cardiomyocytes, filtered and
allowed to settle by gravity. The supernatant was then removed and the cardiomyocytes were
re-suspended in a modified RIPA buffer (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 4% glyc-
erol, 0.5 mM sodium metabisulfite, 1% triton X-100, 0.1% sodium deoxycholate, and 0.05%
SDS) containing 1x phosphatase inhibitor cocktail 1 and 2 (Millipore, cat# 524624 and
524625), 1 mM DTT and 1x protease inhibitors (Fisher Scientific, cat# 88666) and sonicated
(Bioruptor UCD-200) [29].
Adult cardiac fibroblasts were isolated according to protocol 2 of Pinto et al. [30]. Briefly,
hearts were isolated from 8-week old WT mice and minced into 12 to 14 pieces in 1x Hanks
Balanced Salt Solution (HBSS, HyClone, cat# SH30588.01). The heart pieces were transferred
to a digestion solution (1x HBSS, 2 mg/mL collagenase type IV (Worthington, Cat#
LS004188), 1.2 U/mL dispase II (Roche, Cat# 10165859001), and 0.9 mM CaCl2) and incu-
bated at 37˚C for 15 min with gentle rocking. The digestion mix was triturated 12 times using
a 10 mL serological pipette and placed back in the incubator. The trituration was repeated two
more times for a total digestion period of 45 min and the final trituration was performed with
a p1000 pipetteman (Gilson, p1000) [30]. The digestion was transferred to a 15 mL conical
tube with 5 mL of culture media containing DMEM (Thermoscientific, cat# SH30284.02) sup-
plemented with 10% FBS (Sigma, Cat# F2442), and 1% Pen/Strep (Fisher Scientific Cat# 30-
002Cl). The cells were pelleted at 1000 x g for 5 minutes at room temperature. Following aspi-
ration of the supernatant, the pellet was re-suspended in 10 mL of culture medium and plated
on a 10 cm tissue culture dish coated with 0.1% gelatin. Cells were harvested at passage one,
scraped with modified RIPA buffer (see above), and sonicated (Bioruptor UCD-200) for 5
minutes in an ice water bath.
Mouse hearts were removed 1 day, 1 week or 2 weeks after MI injury and the area of infarc-
tion was dissected to generate protein extracts. The tissue was homogenized in modified RIPA
buffer, sonicated for 5 min, centrifuged for 10 min at 12,000 x g at 4˚C and the supernatant
was used for Western analysis. Protein concentrations were quantified using Bradford reagent
(Bio-Rad, Cat#500–0006) according to manufacturer’s instructions and then run on a 7.5%
SDS-PAGE gel for Western blotting. Primary antibodies for periostin (Novus, 1:1000,
Cat#NBP1-30042), TGFBI (Protein Tech (Cat #10188-1-AP or Abcam (Cat# AB170874),
1:1000), sarcomeric α-actin (Abcam (Cat# AB62298), 1:1000), and GAPDH (Fitzgerald (Cat#
10R-G109A), 1:5000) were used for protein detection. Secondary antibodies (LI-COR
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biosciences (Cat# 926–32211), 1:10,000) were incubated for 1 hour at room temperature prior
to imaging on an Odyssey CLx LI-COR scanner [31]. Densitometry was performed for West-
ern blot quantification using Image Studio software version 3.1.
RNA and QPCR
RNA was isolated from MI- or sham-operated hearts 1 week after surgery and either flash-fro-
zen or stored in RNAlater (Ambion, Cat# AM7021) as previously described [31]. Briefly, hearts
were weighed and 1 mL of Trizol (Invitrogen, Cat#15596–026) was added per 50 mg of tissue.
Hearts were homogenized and RNA was isolated according to manufacturer’s instructions
(Invitrogen, Cat#15596–026). The RNA was then run through an RNeasy column (Qiagen,
Cat# 74104) including the optional column used with DNase digestion. Four micrograms of
RNA were used as a template for cDNA synthesis using the Superscript III first strand synthe-
sis kit (Invitrogen, Cat# 18080–051) according to manufacturer’s instructions. Quantitative
real time PCR (QPCR) was performed with 2 μL of this first strand cDNA mix diluted 1 to 10
using the SsoAdvanced Universal SYBR Green Supermix (Bio-Rad, Cat# 172–5275). QPCR
was run on a Bio-Rad CFX96 C1000 real time Thermo Cycler. Primers used for TGFBI are for-
ward 5’-AGATCTGGCAGTCATAGCTTGGCA-3’ and reverse 5’- TGTGAGCTCCAAGATG
CCGTAGTT-3’. Primers for periostin are forward 5’–CAAAGCACACAGTTACCTTTCCA
GGG– 3’ and reverse 5’–GCAGGAAACCCACATTGCATGAGA–3’. Primers used for 18s
rRNA (control) are forward 5’- GTAACCCGTTGAACCCCATT-3’ and reverse 5’- CCAT
CCAATCGGTAGTGACG-3’.
Immunohistochemistry and histology
Histological and immunohistochemical analyses were performed on formalin fixed 5–6 μm
thick paraffin sections, which were then stained with Masson’s trichrome and imaged at 100x
or 200x magnification. Fibrosis was quantified from Masson’s trichrome-stained sections
using Image J software and graphed as percent fibrotic area [29].
Immunohistochemistry was performed as described previously and the following primary
antibodies were used: periostin (Abcam (Cat# AB92460), 1:100), TGFBI (Abcam, 1:100), and
α-actinin (Sigma (Cat# A7811), 1:400) [29]. Alexa Fluor secondary antibodies were used at a
concentration of 1:200 through 1:400 (Cat# A11031, and A11008). Pictures were taken using
confocal microscopy (Nikon A1 Confocal). Cardiomyocyte cross-sectional area was mea-
sured on 200x images stained with wheat germ agglutinin-Alexa Fluor 647 Conjugate
(Thermo Fisher Scientific (Cat# W32466), 1:200), laminin (Sigma (Cat# L9393), 1:50) and
4,6-diamidino-2-phenylindole, dihydrochloride (DAPI, Invitrogen (D1306), 1:5000). Cardi-
omyocytes with a visible central nucleus were used to measure cross sectional area using
Image J software. Centrally nucleated cardiomyocytes were measured across three fields of
each heart.
Statistical analysis
All results are represented as mean ± SEM. Unpaired Students t-test was performed to com-
pare means between two groups. Analysis of variance (ANOVA) with a Newman-Keuls post-
hoc test was used to compare means between multiple groups of the four gene-deleted mouse
lines used with surgical intervention, The log rank Mantel-Cox test was used to compare sur-
vival curves between groups of mice after surgical intervention. A p-value of less than 0.05 was
considered statistically significant.
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Results
TGFBI expression is increased in the heart after injury
Periostin expression is induced in a wide array of tissues following injury, and this induction
of expression appears to be specific to the tissue resident, activated fibroblast [12, 19, 20]. The
closely related family member TGFBI is also induced in areas of injury or cancers of the colon
[9], ovary [6], lung [8], breast [7] and within the injured heart [20]. Here we show that similar
to periostin [12], TGFBI induction is largely specific to the fibroblast, but not the cardiomyo-
cyte, as assessed by Western blotting of protein extracts from isolated cells from this organ (Fig
1A). TgfbimRNA levels were also increased in the heart 7 days post-MI injury compared to
sham-operated mice, although Postn mRNA levels were induced at substantially higher levels
(Fig 1B). The infarct areas of the mouse heart were also isolated after 24 hours, 7 days and 14
days for Western analysis and comparison between periostin and TGFBI expression. The
results show no expression in the sham-operated heart or 24 hours after MI injury, but a simi-
lar profile of induction at both 7 and 14 days after MI with periostin induction being more
prominent (Fig 1C). Consistent with previous data, periostin localized to the peri-infarct area
of hearts after 7days of MI and was deposited within the ECM region around the myocytes
(Fig 1D) [12]. TGFBI was also localized to the infarct area of the heart 1 week after MI in a sim-
ilar ECM-staining pattern (Fig 1D). Both gene products also showed substantial deposition
around cardiac vessels (Fig 1D), especially after pressure overload stimulation as assayed by
immunohistochemistry (S1 Fig).
Cardiac phenotype of Tgfbi null mice with MI injury
Mice genetically engineered for global deletion of Tgfbi [18] were used to examine how induc-
tion of this protein following cardiac injury might functionally impact the heart. By compari-
son, Postn-/- mice were previously shown to have greater lethality following MI injury due to
inadequate scar formation and subsequent ventricular wall rupture [12, 13, 32]. However, here
we observed that Tgfbi-/- mice had no change in overall survival rates following MI injury com-
pared with WT control mice (Fig 2A). The 30–40% of mice that died in each group following
MI injury showed no difference in the rates of underlying ventricular wall rupture. To also
investigate the possibility that periostin expression might compensate for the loss of TGFBI
during the MI healing period we first analyzed protein levels within the MI region of the heart
for both periostin and TGFBI. Indeed, we observed an increase in TGFBI protein levels in the
hearts of Postn-/- mice after MI compared with WT MI injured hearts, yet periostin protein lev-
els where unchanged in the Tgfbi-/- hearts after MI compared with WT mice with MI (Fig 2B,
2C and 2D). These results suggest that periostin is the more dominant family member
expressed in the heart, as only in its absence is the paralog gene Tgfbi induced beyond what
was observed in WT hearts after injury. Interestingly, in the lung where TGFBI has been
reported to play a critical developmental role [18], bleomycin injury significantly induced
TGFBI expression while periostin expression was decreased (S2 Fig), suggesting a reciprocal
compensation pattern in this tissue compared with the heart (which also reflects the domi-
nance of TGFBI in lung over periostin).
Postn/Tgfbi double null mice (DKO) were also generated and examined to further address
compensation or the possibility that one gene dominates over the other in the heart following
MI injury. Importantly, adult DKO mice displayed no baseline phenotype or other observable
cardiac pathology up to 1 year of age (S3 Fig). As previously observed by us [12], Postn-/- mice
again showed greater lethality with higher rates of ventricular wall rupture following MI injury
compared with WT controls (Fig 2E). However, separate groups of Tgfbi-/- mice again showed
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Fig 1. TGFBI and periostin are induced in the heart after injury. (A) Western blot analysis of periostin and TGFBI in isolated
adult cardiomyocytes and fibroblasts. Sarcomeric α-actin was used as a control for cardiomyocyte purity and GAPDH was used
as a loading control. (B) Quantitative real time PCR for Postn and Tgfbi from 1 week sham or MI-operated hearts. mRNA levels
TGFBI functions similar to periostin but is dispensable during cardiac injury
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were normalized to 18s ribosomal RNA. *p<0.05 for both genes in MI-operated animals compared to sham animals using an
unpaired Student’s T-test. n = 3 animals. (C) Western blot analysis for periostin and TGFBI in the infarcted areas isolated from
hearts 24 hours, 7 and 14 days after MI surgery. GAPDH was used as a loading control. Each lane corresponds to protein from
one mouse. (D and E) Quantification of TGFBI (D) and periostin (E) protein levels from the conditions shown in panel C except
that 3 hearts were analyzed in total each. (F) Immunohistochemistry for the indicated markers/proteins on sham or MI-operated
hearts after 1 week. Images were taken at 400x magnification. Scale = 20 μm.
https://doi.org/10.1371/journal.pone.0181945.g001
Fig 2. Loss of Tgfbi does not alter disease progression after MI. (A) Percent survival in the groups of mice shown over 7 days following MI surgery. No
mortality was observed in sham-operated WT or Tgfbi-/- mice. No differences in survival between WT and Tgfbi-/- after MI was detected using the log rank
Mantel-Cox statistical test. (B) Western blot analysis for TGFBI and periostin from isolated infarct areas of the hearts of the indicated groups of mice 7 days
after MI. GAPDH was used as a loading control. (C and D) Quantification of protein levels normalized to GAPDH using densitometry for periostin in WT and
Tgfbi-/--operated hearts and for TGFBI in WT and Postn-/--operated hearts. *p<0.05 vs WT using an unpaired Student’s T-test. (E) Percent survival in the
indicated groups of mice over 7 days after sham or MI surgery. p<0.05 vs WT MI-operated animals using the log rank Mantel-Cox test (F) Percent ventricular
fractional shortening (FS%) as measured by echocardiography in the indicated genotypes of mice 8 weeks after MI. *p<0.05 vs sham. (G) Left ventricular
end diastolic dimension (LVED) as measured by echocardiography in the indicated groups of mice 8 weeks after MI. *p<0.05 vs sham using a parametric
one way ANOVA with a Newman-Keuls post-hoc test.
https://doi.org/10.1371/journal.pone.0181945.g002
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no greater lethality than WT MI injured mice, while DKO mice showed a profile of lethality
and ventricular wall rupture nearly identical to Postn-/- mice, further suggesting that TGFBI
protein induction is of little compensatory value during this injury response (Fig 2E). The
same general reductions in cardiac ventricular fractional shortening or increases in left ven-
tricular end diastolic dimension were detected between sham and MI operated groups of each
genotype and were significantly changed by student T-test, but only some parameters were sig-
nificant by ANOVA when all groups were compared together, and the later statistical results
are shown in the figure as a conservative interpretation of the data (Fig 2F and 2G). However,
the same trends were observed.
Cardiac phenotype of Tgfbi null mice with TAC surgery
To further analyze the role of TGFBI during cardiac injury, mice were subjected to long-term
pressure overload stimulation by TAC, which induces a fibrotic response and reduces cardiac
functional performance. After 12 weeks of TAC all genotypes of mice showed reductions in
ventricular fractional shortening (Fig 3A), increases in heart-weight normalized to body-
weight (Fig 3B), increases in the cross-sectional area of cardiomyocytes in the left ventricle
(Fig 3C) and a roughly similar increase in total ventricular fibrosis (Fig 3E and 3F). Interpreta-
tion of statistical significance behind these results was based on ANOVA, although compari-
son by student T-test between the WT group and any specific genotype showed a significant
difference. However, Postn-/- and Tgfbi-/- mice even by ANOVA showed less pulmonary con-
gestion after 12 weeks of TAC compared with WT controls or the DKO mice (Fig 3D). Pulmo-
nary congestion is often used as an indicator of heart failure. We also observed that Tgfbi-/-
mice displayed a decrease in hypertrophy following 12 weeks of TAC compared with all the
other genotypes of mice by any statistical test (Fig 3B), although we are uncertain as to why
this might be the case. Importantly, there were no differences between the genotypes in pres-
sure gradients across the aortic constrictions. In summary, the data suggest that loss of Tgfbior
the loss of both Tgfbi together with Postn (DKO mice) does not appreciably worsen the cardiac
phenotype of mice following pressure overload stimulation.
Heart specific over-expression of TGFBI
We previously showed that periostin over-expression in the heart using a transgene approach
resulted in a mild but significant degree of cardiac hypertrophy by 32 weeks of age compared
with WT controls, although over-expression of this protein was otherwise innocuous to the
heart and did not increase fibrosis [12]. Here we generated transgenic mice with inducible
over-expression of TGFBI under control of the α-MHC binary tetracycline transactivator
(tTA) regulated system to determine how this protein might impact the heart (Fig 4A) [22].
Western analysis showed robust over-expression of TGFBI in the heart in the double trans-
genic mice (DTG) (Fig 4B). Immunohistochemical analysis of hearts from these DTG mice
showed accumulation of secreted TGFBI protein within the ECM between the cardiomyocytes
of the adult heart similar to its deposition when normally secreted by stress-activated fibro-
blasts (Fig 4C). TGFBI DTG mice also displayed a mild phenotype of concentric cardiac hyper-
trophy with aging (Fig 4D) that was also associated with an increase in ventricular fractional
shortening (Fig 4E), but without a change in left ventricular end diastolic dimension or fibrosis
(Fig 4F and 4G). Following long-term TAC, TGFBI DTG mice showed the same decrease in
ventricular fractional shortening, increases in heart-weight normalized to body-weight, and
increases in lung-weight normalized to body-weight as WT controls with TAC (Fig 4H, 4I and
4J). Together these data suggest that over-expression of TGFBI acts similar to previous results
with periostin over-expression [12], in that it appears to support a greater cardiac growth
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response at baseline without impacting fibrosis or the ability of these hearts to compensate to
long-term pressure overload.
Discussion
Periostin is a matricellular protein that is induced and secreted specifically by activated fibro-
blasts in areas of tissue injury where it accumulates within the ECM to facilitate type 1 collagen
Fig 3. Loss of Tgfbi does not appreciably alter disease progression after long-term TAC. (A) Percent ventricular fractional shortening as measured by
echocardiography 12 weeks after TAC in the indicated groups. *p<0.05 vs sham-operated controls. (B) Heart-weight normalized to body-weight in the
indicated groups of mice after 12 weeks of TAC. *p<0.05 vs sham-operated controls. (C) Cardiomyocyte cross-sectional area from ventricular histological
sections in the indicated groups of mice 12 weeks after MI. *p<0.05 vs sham-operated controls. Four to six hearts were processed from each group, with at
least 3 fields analyzed per histological section. (D) Lung-weight normalized to body-weight in the indicated groups of mice 12 weeks after TAC. *p<0.05 vs
sham-operated controls. (E) Ventricular fibrosis from Masson’s trichrome-stained histological images in the indicated genotypes of mice after 12 weeks of
TAC. *p<0.05 vs sham-operated controls. Four to six hearts were processed from each group, with at least 3 fields analyzed per histological section. (F)
Representative Masson’s trichrome-stained histological heart sections from sham and TAC hearts after 12 weeks of MI. Images were taken at 100x
magnification. Scale bar = 100 μm. All statistical analyses were performed using a parametric one way ANOVA with a Newman-Keuls post-hoc test.
https://doi.org/10.1371/journal.pone.0181945.g003
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maturation and crosslinking, as well as strengthening of the ECM by interactions with tenas-
cin-C, fibronectin and collagen V [33–35]. TGFBI and periostin are family members that con-
tain 4 fasciclin domains with conserved sequence similarity. Similar to periostin, TGFBI is also
induced by transforming growth factor-β (TGFβ) signaling in areas of tissue injury and is
secreted by activated fibroblasts [4, 36]. While both Postn and Tgfbigene expression are
induced by injury events in nearly all tissues evaluated, Postn induction has been most heavily
evaluated in the heart following injury or in cancer cells as they undergo invasion with ECM
remodeling [12] [37–39]. Previous work from us and others has shown that periostin is
required for proper scar formation in the heart after MI injury, such that mice deficient in this
gene undergo lethal rupture [12, 13]. This event was shown to be specific to the cardiac fibro-
blast as targeted ablation of periostin-expressing fibroblasts prevented adverse remodeling in
mice after MI injury or angiotensin II infusion [32]. We also showed that deletion of periostin-
expressing activated fibroblasts from the heart during MI injury compromised scar formation
and results in lethal ventricular wall rupture [40].
Fig 4. Cardiac-specific over-expression of TGFBI. (A) Schematic representation of the double transgenic (DTG) system used to generate cardiac-
specific, doxycycline inducible expression of TGFBI. (B) Western blot analysis of TGFBI in hearts of DTG mice. GAPDH was used as a control. (C)
Immunohistochemistry of heart histological sections at 6 months of age from WT or TGFBI DTG mice. Sections were imaged for the proteins or markers
shown. Scale = 10 μm. (D) Heart-weight (HW) normalized to body-weight (BW) in WT and DTG mice at 6 months of age. *p<0.05 vs WT using an unpaired
Student’s T-test. (E) Percent fractional shortening (FS%) in WT and DTG mice at 6 months of age. *p<0.05 vs WT using an unpaired Student’s T-test. (F)
Left ventricular dimension in diastole (LVED) in WT and DTG mice at 6 months of age as measured by echocardiography. (G) Percent fibrosis measured
from Masson’s trichrome-stained cardiac histological sections from WT and DTG mice at 1 year of age. (H) Assessment of FS% in the indicated groups of
mice over 12 weeks after sham or TAC surgery. (I) HW normalized to BW in the indicated groups of mice after 12 weeks after TAC. *p<0.05 vs
corresponding sham group. (J) Assessment of lung-weight (LW) normalized to BW in the indicated groups of mice after 12 weeks of TAC. *p<0.05 vs
corresponding sham group analyzed by parametric one way ANOVA with a Newman-Keuls post-hoc test.
https://doi.org/10.1371/journal.pone.0181945.g004
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To date, the majority of the literature pertaining to TGFBI has focused on corneal dystro-
phy. TGFBI is a primary disease-causing gene associated with corneal dystrophy where muta-
tions cause protein deposits on the cornea eventually leading to blindness [15, 16]. Tgfbinull
mice were also recently shown to have a pathological lung phenotype as discussed earlier [18].
While a single description of TgfbimRNA induction in the diseased heart from an extensive
array profiling study of the mouse heart was reported [21], almost nothing is known of TGFBI
function in the heart. Moreover, nothing was previously known of the potential for periostin
and TGFBI to function redundantly or if each might possibly have unique roles in selective tis-
sues based on where they are primarily expressed.
Here we observed that TGFBI is induced in the heart with injury, and that this expression is
within fibroblasts. However, TGFBI expression and ECM deposition was noticeably less com-
pared with periostin upon cardiac injury, as assessed by Western blotting and immunohis-
tochemistry. However, lung injury showed the opposite effect with a much greater induction
of TGFBI compared to periostin, hence it is likely that differences in phenotypes and disease
profiles between Postn and Tgfbigene-deleted mice is a reflection of where each gene is pri-
marily expressed across selective tissues. Indeed, this hypothesis is supported by previous work
where periostin and TGFBI are reported to have opposite effects in the lung in mouse models
of bronchopulmonary dysplasia [18, 41]. In response to hyperoxia, Postn null mice displayed
normal alveolar development [41] while Tgfbinull mice at baseline showed alveolar defects
[18].
In the heart, mice deficient for Postn attempted at compensate after MI injury by upregula-
tion of Tgfbi expression. However, loss of the less highly expressed Tgfbigene in the heart dur-
ing MI injury did not result in greater induction of Postn expression, as periostin induction is
presumably already more than sufficient. In support of this conclusion, Postn/Tgfbi double
null mice showed the same degree of defective scar formation and ventricular wall rupture
after MI as Postn single null mice, while single null Tgfbimice were unaffected relative to WT.
To further address if TGFBI and periostin might function similarly in the mouse heart,
apart from differences in expression levels, we engineered TGFBI transgenic mice with heart-
specific expression. TGFBI over-expression, which was deposited within the ECM, induced a
mild degree of concentric cardiac hypertrophy reminiscent of a nearly identical increase of
baseline cardiac hypertrophy observed in periostin heart-specific over-expressing mice at 32
weeks of age [12]. Neither periostin nor TGFBI over-expression was sufficient to induce a
fibrotic response or otherwise impact pressure overload induced fibrosis. These results suggest
that periostin and TGFBI have similar function at the protein level; further suggesting that dif-
ferences in the disease susceptibility phenotype observed between mice lacking either gene is a
reflection of expression dominance in the heart. In the future it would be interesting to insert
the TGFBI cDNA into to Postn locus and create homozygous targeted mice, which if our
hypothesis is correct, such mice lacking periostin protein would be fully compensated by
TGFBI protein induction from the Postn locus because it drives much higher expression in
cardiac fibroblasts with injury events.
Finally, while periostin and TGFBI are highly similar through their 4 fasciclin domains
[42], periostin uniquely contains a C-terminal region that is alternatively spliced [42–44],
which when cleaved can presumably contribute to alterations in protein function [14, 34, 38].
In fact, it has been shown that periostin binding to tenascin-C, fibronectin and collagen V is
enhanced upon loss of the C-terminal tail [33, 35]. These data suggest that the dynamic C-ter-
minal tail of periostin, which is lacking in TGFBI, may give this family member unique func-
tional characteristics. More studies are clearly needed to further dissect the functional
similarities and differences between these two related family members in the heart and other
tissues.
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Supporting information
S1 Fig. TGFBI is induced in TAC hearts. Immunohistochemical analysis of sham and TAC-
operated hearts 12 weeks after surgery stained for TGFBI in green (A) or periostin in green
(B). Red is α-actinin. Blue stain is DAPI for nuclei. Images were taken at 200x magnification
and the scale bar = 50 μm.
(PDF)
S2 Fig. Periostin and TGFBI are differentially regulated in a model of lung injury in the
mouse. (A) Western blot analysis of TGFBI and periostin expression in lung tissue treated
intranasally for 3 weeks with either bleomycin or saline. GAPDH served as a loading control.
(B) Quantification of TGFBI protein expression normalized to GAPDH in saline and bleomy-
cin treated lungs. p<0.05 vs saline. (C) Quantification of periostin protein expression normal-
ized to GAPDH in saline and bleomycin treated lungs. p<0.05 vs saline. An unpaired
students T-test was used for statistical analysis in B and C.
(PDF)
S3 Fig. Baseline characterization of WT, Tgfbi-/-, Postn-/-, and DKO mice. (A, C) Ventricle-
weight normalized to body-weight (VW/BW) of the indicated genotypes of mice after 6
months (A) and 1 year (C) of aging. (B, D) Percent ventricular fractional shortening (FS%) as
measured by echocardiography after 6 months (B) and 1 year (D) of aging. Statistical analysis
was performed using a parametric one way ANOVA with a Newman-Keuls post-hoc test. (E)
Representative Masson’s trichrome-stained cardiac histological sections shown at 100x magni-
fication (6 months of age). Scale bar = 100 μm.
(PDF)
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